New AI-based blood test technology detects over 80% of liver cancers
A new artificial intelligence blood test technology developed and used by Johns Hopkins Kimmel Cancer Center researchers to successfully detect lung cancer in a 2021 study has now detected more than 80% of liver cancers in a new study involving 724 people. The blood test, called DELFI (DNA evaluation of fragments for early interception) detects …
New AI-based blood test technology detects over 80% of liver cancers Read More »